Trial
NCT03365414
A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alberta
Collaborators
—
Condition
Postural Orthostatic Tachycardia Syndrome
Intervention
Albumin (Human) 5%, USP
Why stopped
Withdrawal of support of product for trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19